Provectus Biopharmaceuticals, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-4.1M | $-4.1M | — | $134.8K |
| FY2021 | $-1.0M | $-1.0M | — | $23.7K |
| FY2022 | $-3.0M | $-3.0M | — | $3.0K |
| FY2023 | $-2.6M | $-2.6M | — | $2.9K |
| FY2024 | $-3.3M | $-3.3M | — | $1.3M |